385060002: Prolonged-release oral tablet (dose form)

SNOMED CT Concept\Qualifier value\Pharmaceutical dose form (dose form)\Oral dose form\Modified-release oral tablet (dose form)\Prolonged-release oral tablet

Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2018. Module: SNOMED CT core

Descriptions:

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Prolonged-release oral tablet	Is a	Tablet	false	Inferred relationship	Some
Prolonged-release oral tablet	Is a	Oral tablet	false	Inferred relationship	Some
Prolonged-release oral tablet	Has dose form intended site (attribute)	Oral	true	Inferred relationship	Some
Prolonged-release oral tablet	Is a	Modified-release oral tablet (dose form)	true	Inferred relationship	Some
Prolonged-release oral tablet	Has dose form administration method (attribute)	Swallow (administration method)	true	Inferred relationship	Some
Prolonged-release oral tablet	Has dose form transformation (attribute)	No transformation	true	Inferred relationship	Some
Prolonged-release oral tablet	Has dose form release characteristic (attribute)	Prolonged-release (release characteristic)	true	Inferred relationship	Some
Prolonged-release oral tablet	Has basic dose form (attribute)	Tablet	true	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Clarithromycin (as clarithromycin citrate) 500 mg prolonged-release oral tablet	Has manufactured dose form	True	Prolonged-release oral tablet	Inferred relationship	Some
Product containing precisely tofacitinib (as tofacitinib citrate) 11 milligram/1 each prolonged-release oral tablet (clinical drug)	Has manufactured dose form	True	Prolonged-release oral tablet	Inferred relationship	Some
Product containing precisely tapentadol (as tapentadol hydrochloride) 50 milligram/1 each prolonged-release oral tablet (clinical drug)	Has manufactured dose form	True	Prolonged-release oral tablet	Inferred relationship	Some
Product containing precisely tapentadol (as tapentadol hydrochloride) 150 milligram/1 each prolonged-release oral tablet (clinical drug)	Has manufactured dose form	True	Prolonged-release oral tablet	Inferred relationship	Some
Tapentadol (as tapentadol hydrochloride) 100 mg prolonged-release oral tablet	Has manufactured dose form	True	Prolonged-release oral tablet	Inferred relationship	Some
Product containing precisely tapentadol (as tapentadol hydrochloride) 250 milligram/1 each prolonged-release oral tablet (clinical drug)	Has manufactured dose form	True	Prolonged-release oral tablet	Inferred relationship	Some
Product containing precisely tapentadol (as tapentadol hydrochloride) 200 milligram/1 each prolonged-release oral tablet (clinical drug)	Has manufactured dose form	True	Prolonged-release oral tablet	Inferred relationship	Some
Product containing precisely tamsulosin hydrochloride 400 microgram/1 each prolonged-release oral tablet (clinical drug)	Has manufactured dose form	True	Prolonged-release oral tablet	Inferred relationship	Some
Product containing precisely ranolazine 750 milligram/1 each prolonged-release oral tablet (clinical drug)	Has manufactured dose form	True	Prolonged-release oral tablet	Inferred relationship	Some
Product containing precisely ranolazine 500 milligram/1 each prolonged-release oral tablet (clinical drug)	Has manufactured dose form	True	Prolonged-release oral tablet	Inferred relationship	Some
Tacrolimus 4 mg prolonged-release oral tablet	Has manufactured dose form	True	Prolonged-release oral tablet	Inferred relationship	Some
Product containing precisely tacrolimus 1 milligram/1 each prolonged-release oral tablet (clinical drug)	Has manufactured dose form	True	Prolonged-release oral tablet	Inferred relationship	Some
Tacrolimus 750 microgram prolonged-release oral tablet	Has manufactured dose form	True	Prolonged-release oral tablet	Inferred relationship	Some
Product containing precisely nevirapine 100 milligram/1 each prolonged-release oral tablet (clinical drug)	Has manufactured dose form	True	Prolonged-release oral tablet	Inferred relationship	Some
Product containing precisely conjugated estrogen 625 microgram/1 each prolonged-release oral tablet (clinical drug)	Has manufactured dose form	True	Prolonged-release oral tablet	Inferred relationship	Some
Product containing precisely conjugated estrogen 1.25 milligram/1 each prolonged-release oral tablet (clinical drug)	Has manufactured dose form	True	Prolonged-release oral tablet	Inferred relationship	Some
Mesalazine 1 g prolonged-release oral tablet	Has manufactured dose form	True	Prolonged-release oral tablet	Inferred relationship	Some
Product containing precisely paroxetine (as paroxetine hydrochloride) 12.5 milligram/1 each prolonged-release oral tablet (clinical drug)	Has manufactured dose form	True	Prolonged-release oral tablet	Inferred relationship	Some
Product containing precisely paroxetine (as paroxetine hydrochloride) 37.5 milligram/1 each prolonged-release oral tablet (clinical drug)	Has manufactured dose form	True	Prolonged-release oral tablet	Inferred relationship	Some
Product containing precisely pramipexole (as pramipexole dihydrochloride) 3.15 milligram/1 each prolonged-release oral tablet (clinical drug)	Has manufactured dose form	True	Prolonged-release oral tablet	Inferred relationship	Some
Product containing precisely pramipexole (as pramipexole dihydrochloride) 1.05 milligram/1 each prolonged-release oral tablet (clinical drug)	Has manufactured dose form	True	Prolonged-release oral tablet	Inferred relationship	Some
Product containing precisely pramipexole (as pramipexole dihydrochloride) 2.1 milligram/1 each prolonged-release oral tablet (clinical drug)	Has manufactured dose form	True	Prolonged-release oral tablet	Inferred relationship	Some
Pramipexole (as pramipexole dihydrochloride) 520 microgram prolonged-release oral tablet	Has manufactured dose form	True	Prolonged-release oral tablet	Inferred relationship	Some
Product containing precisely pramipexole (as pramipexole dihydrochloride) 260 microgram/1 each prolonged-release oral tablet (clinical drug)	Has manufactured dose form	True	Prolonged-release oral tablet	Inferred relationship	Some
Product containing precisely paracetamol 1 gram/1 each prolonged-release oral tablet (clinical drug)	Has manufactured dose form	True	Prolonged-release oral tablet	Inferred relationship	Some
Isosorbide mononitrate 30 mg prolonged-release oral tablet	Has manufactured dose form	True	Prolonged-release oral tablet	Inferred relationship	Some
Aciclovir 1.2 g prolonged-release oral tablet	Has manufactured dose form	True	Prolonged-release oral tablet	Inferred relationship	Some
Nicotinic acid 375 mg prolonged-release oral tablet	Has manufactured dose form	True	Prolonged-release oral tablet	Inferred relationship	Some
Product containing precisely finasteride 5 milligram and tamsulosin hydrochloride 400 microgram/1 each prolonged-release oral tablet (clinical drug)	Has manufactured dose form	True	Prolonged-release oral tablet	Inferred relationship	Some
Alfuzosin hydrochloride 10 mg and dutasteride 500 microgram prolonged-release oral tablet	Has manufactured dose form	True	Prolonged-release oral tablet	Inferred relationship	Some
Product containing precisely zolpidem tartrate 12.5 milligram/1 each prolonged-release oral tablet (clinical drug)	Has manufactured dose form	True	Prolonged-release oral tablet	Inferred relationship	Some
Piribedil 50 mg prolonged-release oral tablet	Has manufactured dose form	True	Prolonged-release oral tablet	Inferred relationship	Some
Pramipexole (as pramipexole dihydrochloride) 1.57 mg prolonged-release oral tablet	Has manufactured dose form	True	Prolonged-release oral tablet	Inferred relationship	Some
Pramipexole (as pramipexole dihydrochloride) 2.62 mg prolonged-release oral tablet	Has manufactured dose form	True	Prolonged-release oral tablet	Inferred relationship	Some
Product containing precisely carvedilol phosphate 10 milligram/1 each prolonged-release oral tablet (clinical drug)	Has manufactured dose form	True	Prolonged-release oral tablet	Inferred relationship	Some
Product containing precisely carvedilol phosphate 20 milligram/1 each prolonged-release oral tablet (clinical drug)	Has manufactured dose form	True	Prolonged-release oral tablet	Inferred relationship	Some
Product containing precisely metoprolol tartrate (as metoprolol succinate) 12.5 milligram/1 each prolonged-release oral tablet (clinical drug)	Has manufactured dose form	True	Prolonged-release oral tablet	Inferred relationship	Some
Ambroxol acefyllinate 100 mg prolonged-release oral tablet	Has manufactured dose form	True	Prolonged-release oral tablet	Inferred relationship	Some
Product containing precisely gliclazide 60 milligram/1 each prolonged-release oral tablet (clinical drug)	Has manufactured dose form	True	Prolonged-release oral tablet	Inferred relationship	Some
Product containing precisely amoxicillin 775 milligram/1 each prolonged-release oral tablet (clinical drug)	Has manufactured dose form	True	Prolonged-release oral tablet	Inferred relationship	Some
Product containing precisely gliclazide 60 milligram and metformin hydrochloride 500 milligram/1 each prolonged-release oral tablet (clinical drug)	Has manufactured dose form	True	Prolonged-release oral tablet	Inferred relationship	Some
Aceclofenac 200 mg prolonged-release oral tablet	Has manufactured dose form	True	Prolonged-release oral tablet	Inferred relationship	Some
Sodium valproate 133 mg and valproic acid 58 mg prolonged-release oral tablet	Has manufactured dose form	True	Prolonged-release oral tablet	Inferred relationship	Some
Sodium valproate 333 mg and valproic acid 145 mg prolonged-release oral tablet	Has manufactured dose form	True	Prolonged-release oral tablet	Inferred relationship	Some
Sodium valproate 200 mg and valproic acid 87 mg prolonged-release oral tablet	Has manufactured dose form	True	Prolonged-release oral tablet	Inferred relationship	Some
Product containing precisely lamotrigine 25 milligram/1 each prolonged-release oral tablet (clinical drug)	Has manufactured dose form	True	Prolonged-release oral tablet	Inferred relationship	Some
Product containing precisely lamotrigine 50 milligram/1 each prolonged-release oral tablet (clinical drug)	Has manufactured dose form	True	Prolonged-release oral tablet	Inferred relationship	Some
Lamotrigine 200 mg prolonged-release oral tablet	Has manufactured dose form	True	Prolonged-release oral tablet	Inferred relationship	Some
Lamotrigine 300 mg prolonged-release oral tablet	Has manufactured dose form	True	Prolonged-release oral tablet	Inferred relationship	Some
Lamotrigine 100 mg prolonged-release oral tablet	Has manufactured dose form	True	Prolonged-release oral tablet	Inferred relationship	Some
Lamotrigine 250 mg prolonged-release oral tablet	Has manufactured dose form	True	Prolonged-release oral tablet	Inferred relationship	Some
Alprazolam 1 mg prolonged-release oral tablet	Has manufactured dose form	True	Prolonged-release oral tablet	Inferred relationship	Some
Alprazolam 500 microgram prolonged-release oral tablet	Has manufactured dose form	True	Prolonged-release oral tablet	Inferred relationship	Some
Amisulpride 100 mg prolonged-release oral tablet	Has manufactured dose form	True	Prolonged-release oral tablet	Inferred relationship	Some
Product containing precisely amisulpride 400 milligram/1 each prolonged-release oral tablet (clinical drug)	Has manufactured dose form	True	Prolonged-release oral tablet	Inferred relationship	Some
Product containing precisely amisulpride 200 milligram/1 each prolonged-release oral tablet (clinical drug)	Has manufactured dose form	True	Prolonged-release oral tablet	Inferred relationship	Some
Prazosin (as prazosin hydrochloride) 5 mg prolonged-release oral tablet	Has manufactured dose form	True	Prolonged-release oral tablet	Inferred relationship	Some
Product containing precisely lornoxicam 16 milligram/1 each prolonged-release oral tablet (clinical drug)	Has manufactured dose form	True	Prolonged-release oral tablet	Inferred relationship	Some
Product containing precisely mesalazine 1.2 gram/1 each prolonged-release oral tablet (clinical drug)	Has manufactured dose form	True	Prolonged-release oral tablet	Inferred relationship	Some
Ciprofloxacin (as ciprofloxacin hydrochloride) 574.9 mg and ciprofloxacin 425.2 mg prolonged-release oral tablet	Has manufactured dose form	True	Prolonged-release oral tablet	Inferred relationship	Some
Fostemsavir (as fostemsavir trometamol) 600 mg prolonged-release oral tablet	Has manufactured dose form	True	Prolonged-release oral tablet	Inferred relationship	Some
Cefaclor 500 mg prolonged-release oral tablet	Has manufactured dose form	True	Prolonged-release oral tablet	Inferred relationship	Some

Start Previous Page 4 of 4

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
3636013018	Prolonged-release oral tablet	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
3636014012	Prolonged-release oral tablet (dose form)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
3636019019	Extended-release oral tablet	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
1878701000052113	depåtablett	sv	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Sweden NRC maintained module (core metadata concept)